Collplant Biotechnologies Ltd ADR CLGN

$4.40 +0.45 (11.39%)

Valuation

Market cap
6,585,000
Revenue TTM
$2,370,000
Net income TTM
$-11,490,000
PE ratio
0.00
Forward PE
—
Profit margin
-484.81%
Debt to equity
0.00

Trading

Volume
167,000
Avg volume
462,710
Day's range
$3.87 – $4.70
Shares out
1,444,000
Stochastic %K
92%
Beta
1.79
Analysts
Strong Sell
Price target
$110.00

Price

Company profile

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue filler...

Show more

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. The company has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 73 232 5600
Website
https://collplant.com
Address
Weizmann Science Park, 4 Oppenheimer P.O. Box 4132, Rehovot, Israel

Latest news

Stocktwits

Jessypenny Oct 29, 6:31 PM
watching these tickers running up over 15% today: $CLGN (+17.2%) – Big news catalyst driving volume today after LightSolver signed a paid collaboration agreement with the Israel Ministry of Defense (DDR&D) for its photonic computing platform. Clean breakout through resistance—watching to see if buyers hold this into the close. $TDOC (+28.0%) – Big gap up and squeeze on massive volume. Shorts getting caught here. $PRCH (+25.7%) – Aggressive buying early on. Clean breakout level holding up well so far. $GKOS (+30.1%) – Massive volume surge and step-up in buying today. Institutional money looks active on this one.
0 replies
WallStWireAds Oct 29, 1:43 PM
$CLGN LightSolver Secures Paid Collaboration with the Israel Ministry of Defense for the Development of… >> https://caplynx.io/Gz2BYqs
0 replies
Jessypenny Oct 29, 1:27 PM
$CLGN WOW! https://finance.yahoo.com/technology/ai/articles/lightsolver-secures-paid-collaboration-israel-120000832.html
0 replies
Benny_Cellura Oct 28, 10:55 AM
$CLGN gem`
0 replies
Benny_Cellura Oct 27, 11:49 PM 0 replies
Merlintrader Oct 27, 5:43 PM
$CLGN Stock Hub: CollPlant News, LightSolver Acquisition and Photonic Computing . Laser-based computing meets regenerative medicine. The LightSolver acquisition, the Boeing partnership, published supercomputing research and the 2028 LPU commercial target, with the financing that supports CollPlant’s transformation. https://www.merlintrader.com/collplant-clgn-stock-hub/
1 replies
WallStWireAds Oct 26, 3:45 PM
$CLGN https://financeherald.com/p/9bb424a2-1d8f-4517-b473-c3c25e4e5f34/
0 replies
kareem1988 Oct 22, 3:22 PM
$CLGN interesting post from reddit: https://www.reddit.com/r/pennystocks/comments/1xci8s5/clgn_from_breast_implants_to_deep_tech_lasers/ "My spin: If those milestones are met, LightSolver’s technology and team will mathematically control the vast majority of the combined entity's equity structure, functionally completing a full reverse-like transformation into a pure-play photonic computing company."
0 replies